CARLSBAD, Calif., Oct. 4, 2012 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today that Thomas McLeer has been named the Company's Senior Vice President of U.S. Commercial Operations. As Senior Vice President of U.S. Commercial Operations, Mr. McLeer will have responsibility for U.S. Sales and Marketing, Alphatec Spine's Biologics Division and Research and Development. Mr. McLeer will report to Les Cross, the Company's Chairman and Chief Executive Officer. Mr. McLeer most recently served as Chief Marketing Officer and General Manager of Spinal Operations for Pioneer Surgical, a full-line manufacturer and distributor of spinal implants and biologics, where he had responsibility for the Marketing, Sales, Engineering, Contracts and Customer Service departments. Prior to that, Mr. McLeer was Vice President of Sales and Marketing for Archus Orthopedics where he had responsibility for creating a global strategy focused on growth and development for a newly created spinal implant segment. Mr. McLeer has also held several other executive-level positions at Spinal Concepts, Inc., Interpore Cross, Inc., and Zimmer, Inc. "We are pleased to have Tom join the Alphatec Spine team at this critical juncture of our growth," said Les Cross, Chairman and Chief Executive Officer of Alphatec Spine. "Tom's appointment is an important next step for the Company and its transformation into a market-driven and customer-focused organization. Integrating the teams from our U.S. commercial operations under a single point of leadership strengthens the Company's ability to deliver a continuous flow of successful new products that offer the latest in technology and deliver real value to surgeons, hospitals and patients. Tom's addition complements the progress we have already made in 2012 to prioritize our product development process and speed our time to market for new products, as well as streamline our cost structure and strengthen our margins. We look forward to Tom's contributions to help Alphatec Spine achieve its growth objectives."